SMTL ID : 3mpm.1

LCK complexed with a pyrazolopyrimidine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

monomer

Ligands

1 x 5LK: 4-{(6R,7R)-7-amino-3-[3-(4-methylpiperazin-1-yl)phenyl]-6,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl}phenol(Non-covalent)

5LK.1: 15 residues within 4Å: Chain A: L.17, V.25, A.37, K.39, E.54, M.58, I.80, T.82, E.83, Y.84, M.85, E.86, G.88, L.137 Ligands: EDO.2 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.17, A:A.37, A:K.39, A:T.82, A:L.137 Hydrogen bonds: A:T.82, A:T.82, A:M.85 Water bridges: A:N.87 Salt bridges: A:E.86

1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 7 residues within 4Å: Chain A: K.39, A.134, N.135, L.137, A.147, D.148 Ligands: 5LK.1 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.39, A:K.39

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gommermann, N. et al., New pyrazolo[1,5a]pyrimidines as orally active inhibitors of Lck. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-06-02

Peptides

Tyrosine-protein kinase Lck: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase Lck

Related Entries With Identical Sequence